Douglas Lane & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$525K Sell
1,905
-31
-2% -$8.76K 0.01% 188
2026
Q1
$516K Hold
1,936
0.01% 180
2025
Q4
$533K Sell
1,936
-80
-4% -$22.4K 0.01% 177
2025
Q3
$581K Sell
2,016
-22
-1% -$6.51K 0.01% 172
2025
Q2
$674K Buy
2,038
+344
+20% +$111K 0.01% 166
2025
Q1
$557K Buy
1,694
+58
+4% +$17.5K 0.01% 177
2024
Q4
$452K Buy
1,636
+56
+4% +$17.9K 0.01% 185
2024
Q3
$547K Sell
1,580
-53
-3% -$18.2K 0.01% 181
2024
Q2
$540K Sell
1,633
-152
-9% -$52.4K 0.01% 177
2024
Q1
$648K Buy
+1,785
New +$588K 0.01% 173

Other funds holding CI

Douglas Lane & Associates's CI Position: Q2 2026 in Review

Douglas Lane & Associates reduced its Cigna (CI) stake by 1.6% in Q2 2026, selling an estimated $8.76K and leaving 1,905 shares worth $525K. The position accounts for 0.01% of the portfolio, ranked #188.

Douglas Lane & Associates first reported a position in CI in Q1 2024 and has held it in 10 quarters since. The position peaked at $674K in Q2 2025. 590 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Douglas Lane & Associates held 1,905 shares of Cigna worth $525K as of Q2 2026.
  • Douglas Lane & Associates sold 31 Cigna shares in Q2 2026, an estimated $8.76K.
  • Cigna made up 0.01% of Douglas Lane & Associates's portfolio in Q2 2026, its #188 holding.
  • Douglas Lane & Associates first reported a position in Cigna in Q1 2024 and has held it in 10 quarters since.
  • Douglas Lane & Associates's Cigna position peaked at $674K in Q2 2025.
  • 590 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.